Clinical Spectrum of Mitochondrial Diseases

Seminars in Neurology

Volumn 16, Issue 1, 1996, Pages 11-20

  Fadic, Ricardo ^a   Johns, Donald R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

DNA mutations; Genetic disease; Mitochondrial diseases; Mitochondrial DNA; Multisystem disorders; Myopathies

Indexed keywords

MITOCHONDRIAL DNA;

ANIMAL; GENETICS; HUMAN; METABOLISM; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL ENCEPHALOMYOPATHIES;

EID: 0030090823     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040954     Document Type: Article

References (40)

1. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993; 50:1197-208
2. Johns DR. Mitochondrial DNA and disease. N Engl J Med 1995;333: 638-44
3. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-30
4. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-9
5. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-66
6. Wallace DC. Diseases of the mitochondrial DNA.Annu Rev Biochem 1992;61:1175-212
7. Holt IJ, Harding AE, Cooper JM, Shapira AHV, Toscano A, Clark JB, Morgan-Hughes JA. Mitochondrial myopathies:clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989;26:699-708
8. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-9
9. Larsson NG, Holme E, Kristiansson B, et al. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990;28:131-6
10. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993;3:43-50
11. Zeviani M. Nucleolus-driven mutations of human mitochondrial DNA. J Inherit Metab Dis 1992;15:456-71
12. Johns DR, Threlkeld AB, Miller NR, Hurko O. Multiple mitochondrial DNA deletions in myo-neuro-gastrointestinal encephalopathy syndrome. Am J Ophthalmol 1993;115:108-9
13. Soumalainen A, Kaukonen J, Amati P, et al. An autosomal locus predisposing to deletions of mitochondrial DNA Nature Genet 1995; 9:146-51.
14. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes:a distinctive clinical syndrome. Ann Neurol 1984;16:481-8
15. Leu(UUR) gene associated with MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-3
16. Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-Like episodes (MELAS). Biochim Biophys Acta 1991;1097:238-40
17. Shoffner JM, Lott MT, Lezza AM, et al. Myoclonic epilepsy and ragged red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA-Lys mutation. Cell 1990;61:931-7
18. Silvestri G, Ciafaloni E, Santorelli FM, et al. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 1993;43:1200-6
19. Silvestri G, Moraes CT, Shanske S, et al. A new mtDNA mutation in the tRNALys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992;51:1213-7
20. Nikoskeilainen EK, Savontaus M-L, Wanne OP, et al. Leber's hereditary optic neuroretinopathy, a maternally inherited disease. A genealogic study in four pedigrees. Arch Ophthalmol 1987;105:665-71
21. Johns DR. Genotype-specific phenotypes in Leber hereditary optic neuropathy. Clin Neurosci 1994;2:146-50
22. Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain1995;118:319-37
23. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-33
24. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50:852-8
25. Petty RKH, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy Brain 1986;109:915-38
26. Johnston W, Karpati G, Carpenter S, et al. Late-onset mitochondrial myopathy. Ann Neurol 1995;37:16-23
27. Johns DR, Chen X, Macko C, et al. Sensory neuropathy as the predominant manifestation of multiple mitochondrial DNA deletions. Ann Neurol 1995;38:282
28. Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet 1993;4:289-94
29. Johns DR. Mitochondrial DNA mutation and eye disease. In Wiggs JL, ed: Molecular genetics of ocular disorders. New York: Wiley-Liss, 1994:197-214
30. Austin SG, Thandroyen F, Hecht J, et al. Expanding the phenotypic manifestation of the 8344 mitochondrial DNA mutation. Neurology 1994;44:A403
31. Kadowaki T, Kadowaki H, Mori V, et al. A subtype of diabetes associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-8
32. Johns DR, Stein AG, Wityk R. MELAS syndrome masquerading as herpes simplex encephalitis. Neurology 1993;43:2471-3
33. Isozumi K, Fukuuchi Y, Tanaka K, et al. A MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) mtDNA mutation that induces subacute dementia which mimicks Creutzfeldt-Jakob disease. Int Med 1994;33:543-6.
34. Munnich A, Rustin P, Rotig A, et al. Clinical aspects of mitochondrial disorders J Inherit Metab Dis 1992;15:448-55
35. Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991;41:1043-6
36. Fadic R, Johns DR. Therapeutic approaches to improve energy metabolism. In Beal MF, Bodis-Wolner I, Howell N, eds. Neurodegenerative diseases: mitochondria and free radicals in pathogenesis. New York: John Wiley & Sons (in press)
37. Matthews PM, Ford B, Dandurand RJ, et al. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993;43:884-90
38. Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multicenter double-blind trial. J Neurol Sci 1990;100:70-8
39. De Stefano N, Matthews PM, Ford B, et al. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995;45:1193-8
40. Mashima Y, Hiida Y, Oguchi Y. Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 1992;340: 368-9